Proficio Capital Partners LLC Makes New Investment in ICU Medical, Inc. (NASDAQ:ICUI)

Proficio Capital Partners LLC acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 37,241 shares of the medical instruments supplier's stock, valued at approximately $5,779,000. Proficio Capital Partners LLC owned approximately 0.15% of ICU Medical at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Charles Schwab Investment Management Inc. raised its position in shares of ICU Medical by 1.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock valued at $47,196,000 after purchasing an additional 3,048 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in shares of ICU Medical by 166.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after acquiring an additional 567 shares during the last quarter. US Bancorp DE increased its holdings in shares of ICU Medical by 9.0% in the 4th quarter. US Bancorp DE now owns 3,832 shares of the medical instruments supplier's stock valued at $595,000 after acquiring an additional 315 shares during the last quarter. Illinois Municipal Retirement Fund increased its holdings in shares of ICU Medical by 24.4% in the 4th quarter. Illinois Municipal Retirement Fund now owns 12,813 shares of the medical instruments supplier's stock valued at $1,988,000 after acquiring an additional 2,517 shares during the last quarter. Finally, Wealthspire Advisors LLC increased its holdings in shares of ICU Medical by 6.4% in the 4th quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier's stock valued at $413,000 after acquiring an additional 160 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Remove Ads

ICU Medical Stock Performance

ICUI stock traded down $3.16 during trading on Thursday, reaching $148.09. 218,470 shares of the company's stock were exchanged, compared to its average volume of 255,690. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The company's fifty day moving average price is $156.48 and its 200-day moving average price is $164.65. The firm has a market cap of $3.63 billion, a PE ratio of -32.40 and a beta of 0.73.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 1,373 shares of the company's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 6.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ICUI. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Tuesday. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. Finally, Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, ICU Medical presently has a consensus rating of "Buy" and a consensus target price of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.